About ACRO
Chairman of the Board

Chairman of ACRO Biomedical, Dr. Dar-Jen Hsieh, has years of experience in the biotechnology and healthcare field. He has held industrial, governmental, and academic positions.

Education
  • Ph.D., Cell and Molecular Biology, State University of New York at Buffalo

Current Positions
  • Chairman, ACRO Biomedical Co., Ltd.
  • Director, Taiwan Biotechnology Industry Alliance
  • Director, Taiwan Medical and Biotech Industry Association
  • Director, The Allied Association for Science Park Industries
  • Director, Academia-Industry Consortium for Southern Taiwan Science Park
Past Positions
  • CEO, ACRO Biomedical Co., Ltd.
  • Supervisor, Taiwan Medical And Biotech Industry Association
  • Chairman, Taiwan Supercritical Fluid Association
  • CEO, Sunmax Biotechnology Co., Ltd.
  • Deputy CEO, Institute for Biotechnology and Medicine Industry
  • CEO, PRIT Biotech Co., Ltd.
  • Research Fellow and Head of Business Development, Animal Technology Institute Taiwan
  • President and CEO, Acrobio Investment Consulting Inc.
  • Special Assistant to CEO, Sintong Biotech Co., Ltd.
  • Vice President of Technology, Formosa Biotech Inc.
  • Associate Professor, Kaohsiung Medical University


His Philosophical Approach:

In the past thirty years, Taiwan has stumbled along the way to develop a viable biotechnology and pharmaceutical industry. Struggles of the past laid the foundation of what it is today. Whoever has passion and vision, industry insiders or not, should appreciate these hard-earned accomplishments and continue to work together to nurture this industry in Taiwan.

With R&D as its core, ACRO Biomedical is committed to long-term development of innovative products. Using the most environmentally friendly and cleanest technologies, ACRO Biomedical aims to develop a series of biomaterials for tissue and organ repairs as well as the next generation of regenerative medical products, which will combine drugs, peptides, growth factors, biologics, and even human stem cells with biomaterial scaffolds to further enhance organ and tissue repairs, ultimately improving healthcare and quality of life.